Agenus
AGEN
#8939
Rank
ยฃ0.10 B
Marketcap
ยฃ3.05
Share price
-2.64%
Change (1 day)
12.77%
Change (1 year)

Revenue for Agenus (AGEN)

Revenue in 2025 (TTM): ยฃ81.21 Million

According to Agenus 's latest financial reports the company's current revenue (TTM ) is ยฃ80.13 Million. In 2024 the company made a revenue of ยฃ82.44 Million a decrease over the revenue in the year 2023 that were of ยฃ0.12 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Agenus from 2000 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ81.21 M-1.5%
2024 ยฃ82.44 M-32.8%
2023 ยฃ0.12 B51.43%
2022 ยฃ81.02 M-63.01%
2021 ยฃ0.21 B238.62%
2020 ยฃ64.68 M-43.47%
2019 ยฃ0.11 B294.87%
2018 ยฃ28.97 M-8.66%
2017 ยฃ31.72 M73.42%
2016 ยฃ18.29 M9.24%
2015 ยฃ16.74 M273.67%
2014 ยฃ4.48 M142.76%
2013 ยฃ1.84 M-81.3%
2012 ยฃ9.87 M456.96%
2011 ยฃ1.77 M-18.53%
2010 ยฃ2.17 M5.62%
2009 ยฃ2.06 M13.92%
2008 ยฃ1.8 M-35.28%
2007 ยฃ2.79 M690.95%
2006 ยฃ0.35 M-3.28%
2005 ยฃ0.36 M-0.81%
2004 ยฃ0.36 M-81.32%
2003 ยฃ1.97 M-7.31%
2002 ยฃ2.12 M-32.27%
2001 ยฃ3.14 M959.32%
2000 ยฃ0.29 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Merck
MRK
ยฃ48.18 B 60,028.80%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ31.77 B 39,545.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
ยฃ69.12 B 86,158.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
ยฃ1.95 M-97.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ36.03 B 44,863.45%๐Ÿ‡บ๐Ÿ‡ธ USA